Aortic Dimensions in Patients With Fabry Disease
Launched by UNIVERSITY HOSPITAL, CAEN · May 1, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how Fabry disease affects the size of the aorta, which is the large blood vessel that carries blood from the heart to the rest of the body. Researchers want to learn more about how this condition progresses in adults with Fabry disease by using heart imaging tests like echocardiograms and cardiac MRIs. The goal is to understand the changes that happen over time in the aorta of these patients.
To participate in the study, individuals must be adults who have been genetically diagnosed with Fabry disease and are able to provide consent to join. The study is currently not yet recruiting participants, but it is open to all genders. If you join, you will help researchers gather important information about your heart health related to Fabry disease, which could lead to better care for others in the future. If you decide not to participate, that’s completely fine, and your decision will be respected.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: a adult patients with genetically confirmed Fabry disease must be able to signed informed consent for participation in the study
- Exclusion Criteria:
- • Patient refusal to participate in the study
About University Hospital, Caen
The University Hospital of Caen is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent center for medical education and patient care in Normandy, France, it integrates cutting-edge scientific inquiry with compassionate clinical practice. The hospital collaborates with multidisciplinary teams to conduct rigorous studies aimed at improving treatment outcomes across various medical specialties. By fostering a collaborative environment, the University Hospital of Caen plays a pivotal role in translating research findings into effective therapeutic strategies, ultimately enhancing patient care and contributing to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported